Nayeon Kim
Suwon, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
IFI35 suppresses the transcription of hepatitis B virus cccDNA minichromosome via promoting HNF4α proteasomal degradation.
Journal: Journal of biomedical science
Published: October 22, 2025
Erratum to 'Novel role of MHC class II transactivator in hepatitis B virus replication and viral counteraction' [Clin Mol Hepatol 2024;30:539-560].
Journal: Clinical and molecular hepatology
Published: July 24, 2024
Novel role of MHC class II transactivator in hepatitis B virus replication and viral counteraction.
Journal: Clinical and molecular hepatology
Published: January 22, 2024
Paraoxonase-2 agonist vutiglabridin promotes autophagy activation and mitochondrial function to alleviate non-alcoholic steatohepatitis.
Journal: British journal of pharmacology
Published: April 06, 2023
PRKCSH contributes to TNFSF resistance by extending IGF1R half-life and activation in lung cancer.
Journal: Experimental & molecular medicine
Published: March 08, 2023
Paraoxonase-2 contributes to promoting lipid metabolism and mitochondrial function via autophagy activation.
Journal: Scientific reports
Published: September 08, 2022
Susceptibility of Drug Resistant Hepatitis B Virus Mutants to Besifovir.
Journal: Biomedicines
Published: June 06, 2022
Anti-cancer effect of a quinoxaline derivative GK13 as a transglutaminase 2 inhibitor.
Journal: Journal of cancer research and clinical oncology
Published: January 28, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026